Evidence map›Paper›PMID 29435873›Full record

ArticleInternational journal of clinical oncology2018

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Koichi KidoDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Shingo HatakeyamaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. shingoh@hirosaki-u.ac.jp.ORCID http://orcid.org/0000-0002-0026-4079
Naoki FujitaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Hayato YamamotoDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yuki TobisawaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Tohru YoneyamaDepartment of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Takahiro YoneyamaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yasuhiro HashimotoDepartment of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Takuya KoieDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Ikuya IwabuchiDepartment of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
Masaru OgasawaraDepartment of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
Toshiaki KawaguchiDepartment of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
Chikara OhyamaDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Funding

Japan Society for the Promotion of Science 15H02563Japan Society for the Promotion of Science 15K15579Japan Society for the Promotion of Science 17K11118Japan Society for the Promotion of Science 17K11119Japan Society for the Promotion of Science 17K16768Japan Society for the Promotion of Science 17K16770Japan Society for the Promotion of Science 17K16771
6 · The paper itself

Abstract

backgroundOncologic benefits of laparoscopic radical nephroureterectomy (LNU) are unclear. We aimed to evaluate the impact of surgical approach for radical nephroureterectomy on oncologic outcomes in patients with locally advanced upper tract urothelial carcinoma (UTUC).

methodsOf 426 patients who underwent radical nephroureterectomy at five medical centers between February 1995 and February 2017, we retrospectively investigated oncological outcomes in 229 with locally advanced UTUC (stages cT3-4 and/or cN+). The surgical approach was classified as open nephroureterectomy (ONU) or LNU, and oncologic outcomes, including intravesical recurrence-free survival (RFS), visceral RFS, cancer-specific survival (CSS), and overall survival (OS), were compared between the groups. The inverse probability of treatment weighting (IPTW)-adjusted Cox-regression analyses was performed to evaluate the impact of LNU on the prognosis.

resultsOf the 229 patients, 48 (21%) underwent LNU. There were significant differences in patient backgrounds, including preoperative renal function, lymph-node involvement, lymphovascular invasion, and surgical margins, between the groups. Before the background adjustment, intravesical RFS, visceral RFS, CSS, and OS were significantly inferior in the ONU group than in the LNU group. However, in the IPTW-adjusted Cox-regression analysis, no significant differences were observed in intravesical RFS (hazard ratio [HR], 0.65; P = 0.476), visceral RFS (HR, 0.46; P = 0.109), CSS (HR, 0.48; P = 0.233), and OS (HR, 0.40; P = 0.147).

conclusionSurgical approaches were not independently associated with prognosis in patients with locally advanced UTUC.

Indexed as

AgedFemaleHumansLaparoscopyMaleNeoplasm StagingNephroureterectomyRetrospective StudiesTreatment OutcomeUrologic NeoplasmsLaparoscopicOncologic outcomeRadical nephroureterectomyUpper tract urothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.